Amyris to acquire sweet protein pioneer Oobli betting big on next-gen sugar reduction

By: ICN Bureau

Last updated : November 16, 2026 4:25 pm



Oobli has developed a fermentation-based process to produce sweet proteins naturally found in rare fruits and berries near the equator


Amyris is moving to strengthen its position in the fast-growing alternative sweetener market with the acquisition of Oobli, a pioneer in sweet protein innovation, in a strategic deal that brings together advanced biomanufacturing capabilities and next-generation sugar reduction technology.
 
The acquisition will combine Amyris’ scientific expertise, manufacturing infrastructure and commercial reach with Oobli’s proprietary protein fermentation technology, positioning the two companies to accelerate the development and commercialisation of protein- and peptide-based solutions across multiple industries.
 
The move follows Amyris’ manufacturing capacity expansion earlier this year at its advanced fermentation facility in Barra Bonita, Brazil, and signals a broader push into high-growth markets spanning food and beverages, personal care, flavours and fragrances, and agriculture.
 
“In Oobli, we see a commercial and technology platform that is a great complement to our own,” said Amyris Chief Executive Officer, Kathy Fortmann. 
 
“Oobli is poised to transform how sweetness makes it to market, and we are thrilled to bring our commercial scale and resources to further accelerate the sweet revolution. Further, by bringing Oobli's protein expertise together with our strain engineering, manufacturing scale, and commercial capabilities, we see the potential to broaden our capabilities in food and beverage, personal care, flavor and fragrances, agriculture, and beyond, expanding the ways we can help customers innovate.”
 
Oobli’s sweet protein portfolio will be the first to benefit from the combined platform, putting the spotlight on a technology that could reshape how food and beverage manufacturers approach sugar reduction.
 
Over the past decade, Oobli has developed a fermentation-based process to produce sweet proteins naturally found in rare fruits and berries near the equator.
 
Unlike conventional sugar substitutes, these proteins deliver intense sweetness by binding directly to sweet taste receptors. They are hundreds to thousands of times sweeter than sugar and are metabolised by the body as protein, offering sweetness without gut disruption or blood sugar spikes.
 
Oobli’s portfolio includes Oubli Fruit, Serendipity Berry and Katemfe Fruit Sweet Proteins, scientifically known as brazzein, monellin and thaumatin, respectively. The ingredients have FDA GRAS status and FEMA GRAS affirmation for use as natural flavours.
 
The technology could open new opportunities for manufacturers seeking to cut sugar while retaining taste, particularly as consumer interest in metabolic health and healthier food choices continues to grow.
 
Potential applications span sports nutrition, dairy, beverages, chocolate, bakery products and confectionery, giving brands another tool to meet demand for reduced-sugar and clean-label products.
 
“At Oobli, we have always believed there was a better way to deliver the sweet taste consumers love, without the trade-offs to health and our environment. It is with immense pride that we look back on the breakthroughs we have achieved,” said Oobli Chief Executive Officer Ali Wing. 
 
“Joining forces with Amyris gives us the scale and resources to realize our ambition of making sweet proteins the global standard in sweetness solutions. Sweet proteins are an idea whose time is now.”
 
Beyond sweeteners, the acquisition gives Amyris access to Oobli’s protein engineering expertise, potentially expanding its technology platform and opening new commercial opportunities across several end-markets.
 
Fortmann said the deal reflects the growing importance of aligning biomanufactured ingredients with consumer preferences and market demand.
 
“At Amyris, we’ve seen that biomanufactured solutions win when they align with consumer demand and market needs. Oobli's sweet protein platform does exactly that – giving brands a new way to deliver on sweet taste, sugar reduction, and clean label all at the same time. We could not be more excited to welcome the Oobli team into the Amyris family and collectively realize the synergies between our two innovative platforms.”
 
The acquisition is expected to close in the coming weeks. Amyris said existing customer commitments and brand partnerships will continue uninterrupted as Oobli’s sweet protein portfolio expands under the combined business.

Amyris sweetener Oobli

First Published : November 16, 2026 12:00 am